| A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatie | ohne Phasenangabe | rekrutiert |
| A Global Prospective Observational Registry of Patients With Pompe Disease | — | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumita | Phase II | rekrutiert |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | Phase II | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or | Phase III | rekrutiert |
| A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP | — | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | Phase II | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradi | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intraveno | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chroni | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderat | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of | Phase III | rekrutiert |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atr | Phase II | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy | Phase II | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social An | ohne Phasenangabe | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-N | ohne Phasenangabe | rekrutiert |
| Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn) | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| CytOSorb TreatMent Of Critically Ill PatientS Registry | — | rekrutiert |
| DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrol | Phase III | rekrutiert |
| Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Ado | — | rekrutiert |
| Ecological Momentary Intervention for Reward in Anhedonia | ohne Phasenangabe | rekrutiert |
| Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First | — | rekrutiert |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring S | Phase III | rekrutiert |
| Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety | ohne Phasenangabe | rekrutiert |
| Enoxolone in Major Depression - Biomarker-outcome Relationship | Phase I / Phase II | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application- | ohne Phasenangabe | rekrutiert |
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early P | ohne Phasenangabe | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| Glioblastoma Radiotherapy Using IMRT or Proton Beams | ohne Phasenangabe | rekrutiert |
| Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychothera | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improving Low ASPECTS Stroke Thrombectomy | — | rekrutiert |
| Intensive-neurofeedback Protocol for Children With ADHD: A Proof-of-concept Study Comparing iAPF | ohne Phasenangabe | rekrutiert |
| International (Pediatric) Peritoneal Biobank | — | rekrutiert |
| Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization a | Phase III | rekrutiert |
| Large Language Models to Aid Gynecological Oncology Treatment | ohne Phasenangabe | rekrutiert |
| Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified | Phase IV | rekrutiert |
| Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-F | ohne Phasenangabe | rekrutiert |
| NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High- | — | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pediatric Arm of DZL All Age Asthma Cohort | — | rekrutiert |
| Pediatric Intensive Care Transport Registry | — | rekrutiert |
| Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Mali | Phase I | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer | — | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| STIMPulseControl Ancillary Speech Study | ohne Phasenangabe | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone i | Phase III | rekrutiert |
| Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Ac | ohne Phasenangabe | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or | Phase I / Phase II | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced C | Phase III | rekrutiert |
| Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Sever | — | rekrutiert |
| Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants | — | rekrutiert |
| Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Pat | — | rekrutiert |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adult | Phase I | rekrutiert |
| T-cell Therapy in Patients With PML | Phase II | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The CATALINA Study | — | rekrutiert |
| The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Reg | — | rekrutiert |
| Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate | Phase II | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Vercise™ DBS Dystonia Prospective Study | — | rekrutiert |
| Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocri | Phase II / Phase III | rekrutiert |
| Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study | — | rekrutiert |